Sunday August 20th 2017

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

Objectives Mycophenolate mofetil (MMF) is an immunosuppressive agent, sometimes used as a disease-modifying therapy for multiple sclerosis (MS). Several studies have reported the relative safety of this treatment but, to date, its efficacy has rarely been described. We performed a retrospective study to assess the safety and efficacy of MMF in patients with MS. Methodology Three French MS centres included all of their patients treated by MMF. The main outcome criterion was annualised relapse rate (ARR) in the 1 year period after onset of MMF compared with the 1 year control period. Treatment with another immunosuppressive drug, such as mitoxantrone or cyclophosphamide, in the 2 years preceding initiation of MMF was included in a subgroup analysis. MMF safety and progression of the Ex…

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Jump to original: 

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

Leave a Comment

More from category

Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re
Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re

/About-the-Society/News/Researchers-Co-funded-by-National-MS-Society-Repor [Read More]

U.S. House Democrats Launch Probe Into MS Drug Pricing U.S. House Democrats Launch Probe Into MS Drug Pricing
U.S. House Democrats Launch Probe Into MS Drug Pricing U.S. House Democrats Launch Probe Into MS Drug Pricing

U.S. House Democrats said on Thursday they were launching an investigation into why prices for multiple sclerosis (MS) [Read More]

MassDevice.com +5 | The top 5 medtech stories for August 18, 2017
MassDevice.com +5 | The top 5 medtech stories for August 18, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of [Read More]

Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS
Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS

/About-the-Society/News/Investigators-Recruiting-for-Study-of-ALKS-8700-vs [Read More]

Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS
Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS

/About-the-Society/News/Statement-on-House-Oversight-and-Government-Reform [Read More]